Beijing Tongrentang (SHA:600085) unit Tongrentang Guoyao obtained Hong Kong regulatory approval to sell antelope horn powder capsules in the special administrative region.
The Chinese medicine is indicated for calming liver wind, clearing vision, and cooling blood and treating conditions such as convulsions and epilepsy, according to a Wednesday filing with the Shanghai bourse.
The certificate is valid through May 2031.
Shares of the pharmaceutical company rose 2% in recent trade.
Goldwind Science & Technology (SHE:002202, HKG:2208) plans to repurchase part of its shares worth between 300 million yuan and 500 million yuan, according to a Shenzhen bourse filing on Wednesday.The maximum repurchase per share was 39.84 yuan.The share buyback will be implemented within 12 months after the board of directors' approval.The Chinese wind power company's Shenzhen shares fell by less than 3%, while Hong Kong shares declined 2% during the afternoon trade.
China Railway Signal & Communication (SHA:688009, HKG:3969) said it won five projects during the March to April period, according to a Tuesday filing with the Hong Kong bourse.The railway signal and communication manufacturer's Hong Kong shares fell nearly 2% during Wednesday's afternoon trade.Among the projects is the Jinhua Railway Hub expansion valued at 132 million yuan, and four projects in the urban rail transit market valued at 281 million yuan, 198 million yuan, 150 million yuan and 139 million yuan, respectively.
Angel One (NSE:ANGELONE, BOM:543235) said Hemen Bhatia has resigned as chief executive officer of its asset management business, according to an Indian bourse filing on Tuesday.Shares of the company fell nearly 1% in Wednesday's trade.The resignation will be effective June 18, the filing said.